Acro Biomedical (ACBM) Amortization of Deferred Charges (2022 - 2023)
Acro Biomedical (ACBM) recorded quarterly Amortization of Deferred Charges of $3.1 million in Q2 2023, down 20.48% quarter-over-quarter from $3.9 million in Q1 2023, and down 20.48% on a YoY basis from $3.9 million in Q2 2022.
Acro Biomedical (ACBM) Amortization of Deferred Charges (2022 - 2023) Analysis & Trends
Acro Biomedical's Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $3.1 million for Q2 2023.
- In Q2 2023, Amortization of Deferred Charges fell 20.48% year-over-year to $3.1 million; the TTM figure through Jun 2023 stood at $14.9 million (changed N/A YoY), while the FY2022 annual figure was $15.7 million, up 105.35% from the prior year.
- Amortization of Deferred Charges was $3.1 million for Q2 2023 at Acro Biomedical, down from $3.9 million in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $3.9 million in Q1 2022 to a low of $3.1 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 3.12 Mn |
| Jun 30, 2023 | 3.12 Mn |
| Mar 31, 2023 | 3.93 Mn |
| Mar 31, 2023 | 3.93 Mn |
| Jun 30, 2022 | 3.93 Mn |
| Jun 30, 2022 | 3.93 Mn |
| Mar 31, 2022 | 3.93 Mn |
| Mar 31, 2022 | 3.93 Mn |